Metformin adverse effects
Pro Research Analysisby 
Searched over 200M research papers
Gastrointestinal Adverse Effects of Metformin
Gastrointestinal (GI) side effects are the most common adverse events associated with metformin use. Patients frequently report symptoms such as abdominal pain, diarrhea, nausea, vomiting, and bloating, with these risks being higher compared to placebo and other antidiabetic drugs 1468+1 MORE. Immediate-release formulations of metformin are more likely to cause diarrhea and bloating than extended-release versions . In children and adolescents, GI side effects are also common, with reported rates ranging from 2% to 74% . These GI symptoms can lead to poor compliance or discontinuation of therapy .
Other Notable Adverse Effects: Lactic Acidosis, Vitamin B12 Deficiency, and More
Metformin is associated with rare but serious adverse effects such as lactic acidosis, especially in patients with underlying risk factors like kidney dysfunction. However, the actual incidence of metformin-associated lactic acidosis (MALA) is debated and may be lower than previously thought 69. Long-term use of metformin can also lead to vitamin B12 deficiency, which may result in anemia or neurological symptoms 36. Other reported complications include hepatitis, pancreatitis, coagulation abnormalities, and reactive hypoglycemia, though these are less common 236.
Skin and Metabolic Adverse Events
Pharmacovigilance data have identified additional adverse reactions, including skin eruptions, pemphigoid, and metabolic disturbances such as acute pancreatitis and MELAS syndrome (a rare mitochondrial disorder) . Some of these reactions are newly recognized and require further study for confirmation .
Sex Differences in Adverse Drug Reactions
Women are more likely than men to experience metformin-related adverse drug reactions, particularly in the first weeks after starting treatment. This difference is most pronounced early on and may be related to differences in dosing, as women are often prescribed lower doses over time .
Gut Microbiota and Mechanisms Behind GI Side Effects
Metformin alters the gut microbiota, increasing the abundance of certain bacteria and the production of short-chain fatty acids. These changes are linked to both its glucose-lowering effects and the development of GI symptoms 710. The increase in gut hormones like GLP-1, driven by these microbiota changes, may contribute to both the therapeutic and adverse GI effects of metformin 710.
Strategies to Reduce Adverse Effects
Switching from immediate-release to extended-release formulations can reduce GI side effects . Additionally, adding probiotics to metformin therapy has been shown to decrease the risk of diarrhea, bloating, and constipation, potentially improving tolerability .
Conclusion
Metformin is generally safe and effective, but gastrointestinal side effects are common and can limit its use. Rare but serious adverse events like lactic acidosis and vitamin B12 deficiency should be monitored, especially in at-risk populations. Women may be more susceptible to adverse reactions, particularly early in treatment. Adjusting formulations and considering probiotics may help reduce GI symptoms and improve patient adherence.
Sources and full results
Most relevant research papers on this topic